Home | Welcome to Contract Pharma   
Last Updated Thursday, December 18 2014

Print

Breaking News

December 20, 2012
Aims to identify new targets through shared research  Read More »
December 19, 2012
Products will be sold under a co-branding arrangement  Read More »
December 19, 2012
Adds granulation roller compactor  Read More »
December 19, 2012
Will provide portfolio of Phase I-IV trial services  Read More »
December 19, 2012
Identifies multiple active series to supplement Lilly programs  Read More »
December 18, 2012
Seeks development and commercialization partner  Read More »
December 18, 2012
Will identify and commercialize alternative API technologies  Read More »
December 18, 2012
To market Umetrics chemometrics software  Read More »
December 18, 2012
Stansfield to lead development in Europe, Asia-Pac, and Latin America  Read More »
December 18, 2012
PET imaging agent to support MK-8931 development  Read More »
December 17, 2012
To discover compounds targeting hormone receptor  Read More »
December 17, 2012
Janssen to develop NMDA antagonist treatments  Read More »
December 17, 2012
CMO revenues up 18% in the quarter  Read More »
December 17, 2012
Teva gains access to Korean market  Read More »
December 17, 2012
Glass brings more than 17 years of experience  Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On